ADE LLC’s Pfizer PFE Stock Holding History

ADE LLC’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$258K	Sell	10,708 -320	-3%	-$8.37K	0.11%	83
2026 Q1	$310K	Hold	11,028	–	–	0.15%	72
2025 Q4	$275K	Hold	11,028	–	–	0.13%	78
2025 Q3	$281K	Hold	11,028	–	–	0.14%	75
2025 Q2	$267K	Hold	11,028	–	–	0.14%	67
2025 Q1	$279K	Sell	11,028 -1,367	-11%	-$35.8K	0.16%	62
2024 Q4	$329K	Buy	12,395 +66	+0.5%	+$1.79K	0.2%	60
2024 Q3	$357K	Hold	12,329	–	–	0.22%	57
2024 Q2	$345K	Hold	12,329	–	–	0.23%	55
2024 Q1	$342K	Sell	12,329 -984	-7%	-$27.3K	0.23%	56
2023 Q4	$383K	Sell	13,313 -348	-3%	-$10.5K	0.27%	50
2023 Q3	$453K	Hold	13,661	–	–	0.34%	45
2023 Q2	$501K	Hold	13,661	–	–	0.35%	45
2023 Q1	$557K	Buy	13,661 +3	+0%	+$130	0.4%	41
2022 Q4	$700K	Buy	13,658 +264	+2%	+$12.7K	0.53%	34
2022 Q3	$586K	Hold	13,394	–	–	0.66%	28
2022 Q2	$702K	Hold	13,394	–	–	0.75%	23
2022 Q1	$693K	Hold	13,394	–	–	0.65%	25
2021 Q4	$790K	Hold	13,394	–	–	0.67%	24
2021 Q3	$576K	Sell	13,394 -300	-2%	-$13.3K	0.53%	29
2021 Q2	$536K	Buy	13,694 +300	+2%	+$11.7K	0.49%	30
2021 Q1	$485K	Sell	13,394 -364	-3%	-$12.9K	0.48%	32
2020 Q4	$506K	Buy	+13,758	New	+$505K	0.41%	38

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ADE LLC's PFE Position: Q2 2026 in Review

ADE LLC reduced its Pfizer (PFE) stake by 2.9% in Q2 2026, selling an estimated $8.37K and leaving 10,708 shares worth $258K. The position accounts for 0.11% of the portfolio, ranked #83.

ADE LLC first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $790K in Q4 2021. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

ADE LLC held 10,708 shares of Pfizer worth $258K as of Q2 2026.
ADE LLC sold 320 Pfizer shares in Q2 2026, an estimated $8.37K.
Pfizer made up 0.11% of ADE LLC's portfolio in Q2 2026, its #83 holding.
ADE LLC first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
ADE LLC's Pfizer position peaked at $790K in Q4 2021.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on ADE LLC's 13F filing for Q2 2026, filed 4 Aug 2026.